Ocugen

Ocugen’s Revolutionary Gene Therapy Targets Geographic Atrophy: A Shift in Ophthalmology on the Horizon

MALVERN, PA — Ophthalmology is on the crest of a wave; a paradigm shift heralded by Ocugen, Inc (NASDAQ: OCGN) may be imminent. The Pennsylvania-based biopharmaceutical firm recently crossed a …

Ocugen’s Revolutionary Gene Therapy Targets Geographic Atrophy: A Shift in Ophthalmology on the Horizon Read More


The Wistar Institute

Cutting-Edge Study Connects Gut Health to Aging – New Routes for Chronic Illness Management?

PHILADELPHIA, PA — The Wistar Institute’s associate professor, Dr. Mohamed Abdel-Mohsen, and his team, recently made a ground-breaking discovery, published in the Microbiome. They unveiled a link between viral damage …

Cutting-Edge Study Connects Gut Health to Aging – New Routes for Chronic Illness Management? Read More